about
Cognitive impairment in fibromyalgia.Neurological impressions on the organization of language networks in the human brain.Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-ε3/ε3 Patients With Late-onset Alzheimer Disease Dementia.Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease.Effects of APOE haplotypes and measures of cardiovascular risk over gender-dependent cognitive and functional changes in one year in Alzheimer's disease.Assessment of risk factors for earlier onset of sporadic Alzheimer's disease dementia.Longitudinal lipid profile variations and clinical change in Alzheimer's disease dementia.Associations of Blood Pressure with Functional and Cognitive Changes in Patients with Alzheimer's Disease.Balance impairment does not necessarily coexist with gait apraxia in mild and moderate Alzheimer's disease.Pharmacogenetics of angiotensin-converting enzyme inhibitors in patients with Alzheimer's disease dementia.Assessment of sleep satisfaction in patients with dementia due to Alzheimer's disease.Risk factors for cognitive and functional change in one year in patients with Alzheimer's disease dementia from São Paulo, Brazil.Short-term prognosis for speech and language in first stroke patients.Predictors of Cognitive and Functional Decline in Patients With Alzheimer Disease Dementia From Brazil.Is there correlation between cognition and functionality in severe dementia? the value of a performance-based ecological assessment for Alzheimer's disease.Educational bias in the assessment of severe dementia: Brazilian cutoffs for severe Mini-Mental State Examination.Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer's disease dementia.EFFECTS OF APOE GENE HAPLOTYPES AND MEASURES OF CARDIOVASCULAR RISK OVER COGNITIVE AND FUNCTIONAL DECLINE IN ONE YEAR IN PATIENTS WITH ALZHEIMER'S DISEASE DEMENTIAGRIN1 GENOTYPES AND APOE GENE HAPLOTYPES AFFECT THE AGE AT ONSET OF ALZHEIMER'S DISEASE DEMENTIA BUT NOT COGNITIVE OR FUNCTIONAL RESPONSE TO MEMANTINEPHARMACOGENETICS OF BRAIN-PENETRATING ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN DEMENTIA DUE TO ALZHEIMER'S DISEASEPHARMACOGENETICS OF CHOLESTEROL-LOWERING DRUGS IN PATIENTS WITH DEMENTIA DUE TO ALZHEIMER'S DISEASERISK FACTORS FOR COGNITIVE CHANGE IN PATIENTS WITH DEMENTIA DUE TO ALZHEIMER'S DISEASE FROM SÃO PAULO, BRAZILImpact of cardiovascular risk factors over age of Alzheimer's disease onset in patients with low schoolingSemantic aphasia as a sole manifestation of acute strokeA patient with primary progressive aphasia developing dementia due to Alzheimer's diseaseLifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer's DiseaseSelected LDLR and APOE Polymorphisms Affect Cognitive and Functional Response to Lipophilic Statins in Alzheimer's Disease
P50
Q38109575-3DE9416F-957C-4400-AA43-AD1BB0827DBEQ38980484-4E2C1613-8825-4A5C-B6FC-812D437DD58BQ41048820-B1107CCB-B66A-4542-9619-4DE3B02A291BQ44192885-7ED1A59B-2210-406A-AA04-4E01DB5C747CQ47590293-946E44AB-137F-4813-893A-B96B1B323F1EQ47762013-3B0A23C5-555A-4177-A264-2EEB2B7CCAC5Q47781351-76C95397-DEF7-40AB-B2E7-5A2B66E5FE27Q47985361-C83C872B-B2EE-4A4D-8538-1695144D4A18Q47997036-DF681246-AAFD-4B13-B253-9ADF25F421D4Q48017197-0156BEB5-D402-4643-B0F1-BF7D6E7A3360Q48032083-8E7E931A-944D-49C4-82E5-0466FB8BC4B0Q48068550-38C5DFD4-718E-4774-AB3D-DA739D9842F3Q48430618-42C4C390-5FA3-402C-92F4-B0423ABFFA8DQ50557092-34F20783-C877-4D54-BB76-152731B1C8A8Q50611564-0CA3C9E9-7C75-4414-932F-E50F98640D89Q50647364-B80E9168-5C9B-4354-B9B6-04A885627C2EQ51183693-8B8D16B5-92DC-44C2-9912-9B24B9F9E1A2Q60440036-523E4969-9679-4222-B0D9-FDDDC77422A0Q60440039-8CA61776-49A8-4E8D-95C0-89B54C4240BEQ60440057-437236E6-4FF7-4142-B7B7-D864686C1C21Q60440058-2632151F-D3E2-4D84-976C-F8FCD673C91AQ60440059-3C397FBD-1EAB-4402-A9C3-64AE0A794AB4Q60440143-D0049B7B-A499-482A-A381-6BCD3ABEF8EBQ83225844-CC13CB67-A7D9-41EC-8091-AE5497F271BEQ84631149-657EFF25-4A77-4C83-BC2C-F22864BCDE51Q91160616-B59D05EB-D3FA-4D72-A2F4-96029A3D4AD5Q96034195-04859955-8809-4BF3-A8CB-70A18E459D82
P50
description
researcher ORCID ID = 0000-0002-8311-0859
@en
wetenschapper
@nl
name
Fabricio Ferreira de Oliveira
@ast
Fabricio Ferreira de Oliveira
@en
Fabricio Ferreira de Oliveira
@es
Fabricio Ferreira de Oliveira
@nl
type
label
Fabricio Ferreira de Oliveira
@ast
Fabricio Ferreira de Oliveira
@en
Fabricio Ferreira de Oliveira
@es
Fabricio Ferreira de Oliveira
@nl
prefLabel
Fabricio Ferreira de Oliveira
@ast
Fabricio Ferreira de Oliveira
@en
Fabricio Ferreira de Oliveira
@es
Fabricio Ferreira de Oliveira
@nl
P108
P106
P1153
35572945400
P21
P31
P496
0000-0002-8311-0859